Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy
- PDF / 456,659 Bytes
- 6 Pages / 595.276 x 793.701 pts Page_size
- 50 Downloads / 201 Views
Pre-Meeting Report
Interaction • Innovation • Integration • Exchange • Translation • Leadership
Guiding cancer immunotherapy from bench to bedside
www.sitcancer.org
Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy Melief et al. Melief et al. Journal of Translational Medicine 2011, 9:107 http://www.translational-medicine.com/content/9/1/107 (8 July 2011)
Melief et al. Journal of Translational Medicine 2011, 9:107 http://www.translational-medicine.com/content/9/1/107
REVIEW
Open Access
Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy Cornelis JM Melief1, John J O’Shea2 and David F Stroncek3* Abstract The field of cellular therapy of cancer is moving quickly and the issues involved with its advancement are complex and wide ranging. The growing clinical applications and success of adoptive cellular therapy of cancer has been due to the rapid evolution of immunology, cancer biology, gene therapy and stem cell biology and the translation of advances in these fields from the research laboratory to the clinic. The continued development of this field is dependent on the exchange of ideas across these diverse disciplines, the testing of new ideas in the research laboratory and in animal models, the development of new cellular therapies and GMP methods to produce these therapies, and the testing of new adoptive cell therapies in clinical trials. The Summit on Cell Therapy for Cancer to held on November 1 and 2, 2011 at the National Institutes of Health (NIH) campus will include a mix of perspectives, concepts and ideas related to adoptive cellular therapy that are not normally presented together at any single meeting. This novel assembly will generate new ideas and new collaborations and possibly increase the rate of advancement of this field. Review On November 1 and 2, 2011 at the National Institutes of Health (NIH) campus in Bethesda, Maryland a multidisciplinary summit of laboratory and clinical investigators and individuals involved in the clinical use, manufacture, evaluation and regulation of cellular therapies for the treatment of cancer will meet to discuss the most recent advances and promising cellular therapies of cancer (http://www.sitcancer.org/meetings/am11/ summit11). The meeting is sponsored by the Society for Immunotherapy of Cancer (SITC). The purpose of this Summit is to bring clinical and laboratory investigators and those involved with producing, assessing and regulating cellular therapies, together to present and discuss important scientific and technical advances that currently or will soon impact the field. The Summit is important because this field is moving quickly and the issues involved with its advancement are complex and wide ranging. Regular, more focused immune therapy of cancer meetings remain important * Correspondence: [email protected] 3 Department of Transfusion Medicine Clinical Center, NIH 10 Center DriveMSC-1288 Building 10, Room 3C72
Data Loading...
